Diltiazem Drug Class
Diltiazem is a benzothiazepine calcium channel blocker (calcium antagonist), which is one of three distinct subclasses of calcium channel blockers along with dihydropyridines and phenylalkylamines. 1
Classification Details
Calcium channel blockers are divided into three chemically distinct subclasses with differing pharmacological properties 1:
- Benzothiazepines (such as diltiazem)
- Dihydropyridines (such as nifedipine, amlodipine)
- Phenylalkylamines (such as verapamil)
Mechanism of Action
Diltiazem functions as a calcium ion cellular influx inhibitor (slow channel blocker) that blocks L-type calcium channels. 2 The drug works by:
- Slowing AV nodal conduction and increasing refractoriness 3
- Causing coronary and peripheral vasodilation 4
- Producing negative chronotropic (heart rate lowering) and dromotropic (conduction slowing) effects 4
- Having minimal negative inotropic effects in patients with normal ventricular function 4
Distinguishing Pharmacological Characteristics
Diltiazem is classified as a non-dihydropyridine calcium channel blocker, which distinguishes it from dihydropyridines in several important ways 1:
- Vasodilatory effects: Diltiazem produces the least peripheral arterial vasodilation among calcium channel blockers, whereas nifedipine and amlodipine produce the most marked vasodilation 1
- Cardiac effects: Unlike dihydropyridines, diltiazem has significant direct effects on AV conduction and heart rate 1
- Myocardial depression: Non-dihydropyridine calcium channel blockers (diltiazem and verapamil) are myocardial depressants and generally not well tolerated in heart failure 1
Clinical Implications of Classification
The benzothiazepine classification has important therapeutic implications:
- All calcium channel blocker subclasses cause similar coronary vasodilation, making them effective for vasospastic angina 1
- Diltiazem and verapamil show similar efficacy in relieving anginal symptoms and appear equivalent to beta-blockers 1
- AV block may be induced by non-dihydropyridines (diltiazem and verapamil), requiring caution in patients with conduction abnormalities 1
- Diltiazem should be avoided in patients with significantly impaired left ventricular function due to its myocardial depressant effects 1